FeesSafety
Pluang+

Optimism CTO to speak at Ethereum Institutional Forum, highlighting Ethereum Layer 2 and OP Stack developments.

Protocol Fundamentals
03 Nov 2026, 01:03 WIB
Tokenpost
View Source
Neutral
Optimism CTO to speak at Ethereum Institutional Forum, highlighting Ethereum Layer 2 and OP Stack developments.

Optimism co-founder and CTO Karl Floersch is scheduled to speak at the Ethereum Institutional Forum in London, which connects Ethereum's technical roadmap with institutional finance. The forum will discuss topics like post-quantum readiness, tokenization, and custody, featuring executives from major firms such as J.P. Morgan and BlackRock. Optimism's OP Stack, an open-source software for Ethereum Layer 2 networks, currently supports 54 mainnet chains including Base, though Base plans to move away from the OP Stack in the coming months. As of September 2026, OP Stack chains secured $22.2 billion in total value, with significant assets in DeFi and stablecoins, underscoring its growing importance in the Ethereum ecosystem.

The story about Optimism CTO Karl Floersch speaking at the London Ethereum Forum is presented with market data for major cryptocurrencies on Pluang. For readers following the crypto market, here is Pluang's snapshot as of Nov 03, 2026 05:41 WIB: out of 50 major cryptocurrencies, 5 rose and 44 fell. Notable movers include ONE at Rp20 with a 1-day change of -4.21% and a 95% sell order activity, SAND at Rp806 with a -4.08% change and balanced buy/sell activity, and YFI at Rp34,890,432 with a -3.81% change and 63% buy order activity.

More News

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
1 hour ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
1 hour ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
3 hours ago
Man regrets selling 266 Bitcoin at $200 each during 2015 market bottom.

Man regrets selling 266 Bitcoin at $200 each during 2015 market bottom.

A video shared by The Bitcoin Historian recounts an unnamed man's regret over selling 266 Bitcoin at $200 per coin during the 2015 market bottom. The sale is highlighted as a missed opportunity given Bitcoin's subsequent price rise. This story unders...

Market News
Neutral
5 hours ago
Apple's inventory jumps 31% in Q4 amid rising memory costs, impacting margins and device pricing.

Apple's inventory jumps 31% in Q4 amid rising memory costs, impacting margins and device pricing.

Apple's inventory surged 31.1% in fiscal Q4, reaching $14.54 billion, driven by increased stockpiling of computer memory amid unprecedented price hikes. The company’s gross margin forecast of 45-46% for the December quarter reflects these higher memo...

Company Fundamentals
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App